Dengue vaccine shows promise in massive child trial

NCT ID NCT02747927

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new dengue vaccine in over 20,000 healthy children aged 4 to 16 years. The goal was to see if two doses could prevent dengue fever caused by any of the four dengue virus types. The vaccine was given as a shot under the skin and compared to a placebo. Results showed the vaccine reduced the number of dengue cases and hospitalizations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Associacao Obras Sociais Irma Dulce Hospital Santo Antonio

    Salvador, Estado de Bahia, 40415-000, Brazil

  • Calle Alexander Fleming No. 90 Esquina 37, Ensanche La Fe

    Santo Domingo, Distrito Nacional Santo Domingo, 10514, Dominican Republic

  • Centro De Vacunacion Internacional, S.A. (Cevaxin)

    Panama City, 10662, Panama

  • Centro De Vacunacion Internacional, S.A. (Cevaxin) Sede 24 de Diciembre

    Panama City, Panama

  • Centro De Vacunacion Internacional, S.A. (Cevaxin) Sede Plaza Carolina

    Panama City, Panama

  • Centro De Vacunacion Internacional, S.A.(Cevaxin) - La Chorrera

    Panama City, Panama

  • Centro de Atencion e Investigacion Medica S.A - CAIMED - Aguazul - PPDS-PV

    Aguazul, Casanare Department, Colombia

  • Centro de Atencion e Investigacion Medica S.A - CAIMED - Yopal - PPDS-PV

    Yopal, Casanare Department, Colombia

  • Centro de Atencion e Investigacion Medica S.A. - CAIMED - Acacias - PPDS-PV

    Acacías, Meta Department, 507001, Colombia

  • Centro de Estudios em Infectologia Pediatrica SAS (CEIP S.A.S)

    Cali, San Fernando, Colombia

  • Centro de Estudos e Pesquisa em Molestias Infecciosas LTDA (CPCLIN)

    Cidade Alta, Natal - RN, 59025-050, Brazil

  • Colombo North Teaching Hospital

    Ragama, 11010, Sri Lanka

  • Colombo South Teaching Hospital

    Dehiwala, 10250, Sri Lanka

  • Dela Salle Health Sciences Institute

    Dasmariñas, Cavite, 4114, Philippines

  • Hospital Maternidad Nuestra Senora de Altagracia

    Santo Domingo, Distrito Nacional Santo Domingo, 10204, Dominican Republic

  • Lady Ridgeway Hospital for Children

    Colombo, 00800, Sri Lanka

  • Las Pinas Health Center A

    Las Piñas, Philippines

  • Las Pinas Health Center D

    Las Piñas, Philippines

  • Negombo General Hospital

    Negombo, 11500, Sri Lanka

  • Philippines-AFRIMS Virology Research Unit

    Cebu City, Cebu, 6000, Philippines

  • Phramongkutklao Hospital

    Bangkok, Bangkok, 10400, Thailand

  • Research Institute for Tropical Medicine

    City of Muntinlupa, 1781, Philippines

  • Srinagarind Hospital

    Khon Kaen, 40002, Thailand

  • The Hospital for Tropical Diseases

    Bangkok, Bangkok, 10270, Thailand

  • Universidad Nacional Autonoma de Nicaragua

    León, Nicaragua

  • Universidade Federal Do Espirito Santo Hospital Universitario Cassiano Antonio de Moraes HUCAM

    Vitória, Espírito Santo, 29040-091, Brazil

  • Universidade Federal de Mato Grosso do Sul

    Campo Grande, Mato Grosso do Sul, 79070-900, Brazil

  • University of the Philippine Manila

    Ermita, 1000, Philippines

More trials for these conditions

Other studies related to the condition(s) this trial covers.